BI Asset Management Fondsmaeglerselskab’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,253
Closed -$799K 714
2022
Q3
$799K Buy
3,253
+261
+9% +$70.5K 0.04% 227
2022
Q2
$741K Buy
2,992
+1,789
+149% +$483K 0.03% 258
2022
Q1
$398K Sell
1,203
-1,880
-61% -$579K 0.02% 328
2021
Q4
$1.11M Hold
3,083
0.04% 242
2021
Q3
$1M Sell
3,083
-500
-14% -$169K 0.04% 251
2021
Q2
$1.12M Hold
3,583
0.04% 267
2021
Q1
$1.14M Sell
3,583
-4,794
-57% -$1.53M 0.05% 243
2020
Q4
$2.72M Sell
8,377
-3,693
-31% -$1.02M 0.12% 135
2020
Q3
$3.34M Buy
12,070
+2,954
+32% +$851K 0.15% 127
2020
Q2
$2.2M Buy
+9,116
New +$1.83M 0.11% 171
2020
Q1
Sell
-883
Closed -$151K 398
2019
Q4
$151K Sell
883
-300
-25% -$55.6K 0.01% 295
2019
Q3
$210K Buy
1,183
+413
+54% +$89.3K 0.01% 336
2019
Q2
$201K Buy
+770
New +$204K 0.01% 221

Other funds holding ABMD

BI Asset Management Fondsmaeglerselskab's ABMD Position: Q4 2022 in Review

BI Asset Management Fondsmaeglerselskab sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,253 shares — an estimated $799K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in ABMD in Q2 2019 and held it in 13 quarters. The position peaked at $3.34M in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 3,253 Abiomed Inc shares in Q4 2022, an estimated $799K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Abiomed Inc in Q2 2019 and held it in 13 quarters.
  • BI Asset Management Fondsmaeglerselskab's Abiomed Inc position peaked at $3.34M in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q4 2022, filed 13 Feb 2023.